Voxelotor: A new kid on the block in the treatment of sickle cell disease.

Çanak B., Eşkazan A. E.

British journal of clinical pharmacology, cilt.88, ss.2564-2565, 2022 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 88
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1111/bcp.15249
  • Dergi Adı: British journal of clinical pharmacology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, EMBASE, International Pharmaceutical Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.2564-2565
  • Anahtar Kelimeler: HOPE trial, hydroxycarbamide, sickle cell disease, voxelotor, HYDROXYUREA
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet